New Century Speech-Language Pathology P C is categorized under Pathologists in Bayside, NY and active since 2009.
New Century Speech-Language Pathology P C was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pathologists business, which does work in the B2C market, and is classified as a Pathologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Juan Gonzalez at the company’s single location by writing to 21005 43rd Avenue Apartment 1g, Bayside, New York NY 11361 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | New Century Speech-Language Pathology P C |
| Contact Person: | Juan Gonzalez |
| Address: | 21005 43rd Avenue Apartment 1g, Bayside, New York 11361 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pathologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
New Century Speech-Language Pathology P C was started in 2009 to provide professional Pathologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Juan Gonzalez for inquiries that concern New Century Speech-Language Pathology P C by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of New Century Speech-Language Pathology P C can be found at the coordinates as well as the street address 21005 43rd Avenue Apartment 1g in Bayside, New York 11361.
For its online presence, you may visit New Century Speech-Language Pathology P C’s website at and engage with its social media outlets through on Twitter and on Facebook.